Table of contents
Gastroesophageal reflux disease
What's new
Updated 2024 AGA guidelines on the use of potassium-competitive acid blockers in acid-related disorders.
Background
Overview
Guidelines
Key sources
Screening and diagnosis
More topics in this section
Differential diagnosis
Classification and risk stratification
Diagnostic investigations
More topics in this section
Ambulatory esophageal reflux monitoring
Esophageal manometry
Screening for H. pylori infection
Evaluation for gastroparesis
Diagnostic procedures
Medical management
More topics in this section
Maintenance therapy
Management of PPI side effects
Potassium-competitive acid blockers
Non-acid suppressive therapies
Nonpharmacologic interventions
More topics in this section
Weight loss
Smoking cessation
Sleep-related interventions
Therapeutic procedures
More topics in this section
Medigus ultrasonic surgical endostapler
Stretta radiofrequency ablation
Magnetic sphincter augmentation
Perioperative care
Surgical interventions
More topics in this section
Technical considerations for antireflux surgery
Bariatric surgery
Specific circumstances
More topics in this section
Pediatric patients (diagnostic imaging)
Pediatric patients (upper gastrointestinal endoscopy)
Pediatric patients (manometry)
Pediatric patients (pH monitoring)
Pediatric patients (biomarkers)
Pediatric patients (trial of transpyloric/jejunal feeding)
Pediatric patients (trial of PPIs)
Pediatric patients (dietary modifications)
Pediatric patients (transpyloric/jejunal feeding)
Pediatric patients (positioning therapy)
Pediatric patients (acid suppression therapy)
Pediatric patients (prokinetics)
Pediatric patients (probiotics)
Pediatric patients (alternative and complementary medicine)
Pediatric patients (parental/patient counseling)
Pediatric patients (assessment of treatment response)
Pediatric patients (indications for referral)
Pediatric patients (indications for antireflux surgery)
Pediatric patients (alternatives to fundoplication)
Preterm infants
Patients with peptic strictures
Patients with extraesophageal symptoms (evaluation)
Patients with extraesophageal symptoms (management)
Follow-up and surveillance
More topics in this section
Management of refractory disease